-
17897-1A selective inhibitor of BRD9 and BRD7 bromodomains (Kds = 14.1 and 239 nM IC<sub>50</sub>s = 75 nM and 3.
-
17897-10A selective inhibitor of BRD9 and BRD7 bromodomains (Kds = 14.1 and 239 nM IC<sub>50</sub>s = 75 nM and 3.
-
17897-500A selective inhibitor of BRD9 and BRD7 bromodomains (Kds = 14.1 and 239 nM IC<sub>50</sub>s = 75 nM and 3.
-
15264-1A cell permeable, ATP-competitive inhibitor of the four vertebrate isoforms of RSK, RSK1-4 (IC<sub>50</sub>s = 31, 24, 18, and 15 nM, respectively) also significantly inhibits PLK1, Aurora B, MELK, and MST2 at 100 nM.
-
15264-10A cell permeable, ATP-competitive inhibitor of the four vertebrate isoforms of RSK, RSK1-4 (IC<sub>50</sub>s = 31, 24, 18, and 15 nM, respectively) also significantly inhibits PLK1, Aurora B, MELK, and MST2 at 100 nM.
-
15264-5A cell permeable, ATP-competitive inhibitor of the four vertebrate isoforms of RSK, RSK1-4 (IC<sub>50</sub>s = 31, 24, 18, and 15 nM, respectively) also significantly inhibits PLK1, Aurora B, MELK, and MST2 at 100 nM.
-
12032-10A small molecule antagonist of HNF4&alpha that at 20 &muM reduces endogenous insulin gene expression by as much as 50-fold in T6PNE cells induces hepatic steatosis in vivo and is cyctotoxic to human hepatocellular carcinoma cell lines.
-
12032-5A small molecule antagonist of HNF4&alpha that at 20 &muM reduces endogenous insulin gene expression by as much as 50-fold in T6PNE cells induces hepatic steatosis in vivo and is cyctotoxic to human hepatocellular carcinoma cell lines.
-
12032-50A small molecule antagonist of HNF4&alpha that at 20 &muM reduces endogenous insulin gene expression by as much as 50-fold in T6PNE cells induces hepatic steatosis in vivo and is cyctotoxic to human hepatocellular carcinoma cell lines.
-
16754-10A natural non-selective phytotoxin that is converted in vivo to the active agent phosphinothricin, which inhibits glutamine synthetase (Ki = 6.1 µM) used in the selection of transgenic plants that express the bar gene, usually under the
-
16754-100A natural non-selective phytotoxin that is converted in vivo to the active agent phosphinothricin, which inhibits glutamine synthetase (Ki = 6.1 µM) used in the selection of transgenic plants that express the bar gene, usually under the
-
16754-50A natural non-selective phytotoxin that is converted in vivo to the active agent phosphinothricin, which inhibits glutamine synthetase (Ki = 6.1 µM) used in the selection of transgenic plants that express the bar gene, usually under the